Edition:
United Kingdom

Johnson & Johnson (JNJ.N)

JNJ.N on New York Stock Exchange

140.45USD
19 Jun 2019
Change (% chg)

$0.22 (+0.16%)
Prev Close
$140.23
Open
$140.15
Day's High
$140.96
Day's Low
$140.07
Volume
1,649,355
Avg. Vol
1,949,659
52-wk High
$148.97
52-wk Low
$120.11

About

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer... (more)

Overall

Beta: 0.71
Market Cap(Mil.): $372,318.50
Shares Outstanding(Mil.): 2,655.06
Dividend: 0.95
Yield (%): 2.71

Financials

  JNJ.N Industry Sector
P/E (TTM): 25.96 32.51 37.25
EPS (TTM): 5.40 -- --
ROI: 11.72 12.52 12.15
ROE: 24.02 13.83 16.99

FDA advisory panel recommends approval of TB Alliance's tuberculosis treatment

Independent experts of an FDA advisory panel voted in favor of the not-for-profit TB Alliance's treatment for drug resistant tuberculosis, as a part of a three-drug combination regimen.

06 Jun 2019

FDA advisory panel recommends approval of TB Alliance's tuberculosis treatment

June 6 Independent experts of an FDA advisory panel voted in favor of the not-for-profit TB Alliance's treatment for drug resistant tuberculosis, as a part of a three-drug combination regimen.

06 Jun 2019

Exclusive: U.S. SEC probes Siemens, GE, Philips in alleged China medical equipment scheme - sources

SAO PAULO The U.S. Securities and Exchange Commission is investigating Siemens AG, Philips NV and General Electric Co for allegedly using local middlemen to negotiate bribes with Chinese government and hospital officials to sell medical equipment, two U.S. sources with knowledge of the matter told Reuters.

04 Jun 2019

Exclusive: SEC probes Siemens, GE, Philips in alleged China medical equipment scheme

SAO PAULO The U.S. Securities and Exchange Commission is investigating Siemens AG, Philips NV and General Electric Co for allegedly using local middlemen to negotiate bribes with Chinese government and hospital officials to sell medical equipment, two U.S. sources with knowledge of the matter told Reuters.

04 Jun 2019

EXCLUSIVE-U.S. SEC probes Siemens, GE, Philips in alleged China medical equipment scheme -sources

SAO PAULO, June 4 The U.S. Securities and Exchange Commission is investigating Siemens AG, Philips NV and General Electric Co for allegedly using local middlemen to negotiate bribes with Chinese government and hospital officials to sell medical equipment, two U.S. sources with knowledge of the matter told Reuters.

04 Jun 2019

J&J, pension funds file tag-team dismissal motions in shareholder arbitration case

Groundbreaking litigation can make for strange alliances.

03 Jun 2019

J&J's greed helped fuel U.S. opioid crisis, Oklahoma claims at trial

NORMAN, Okla. Johnson & Johnson's greed led the drugmaker to use deceptive marketing to create an oversupply of painkillers that fueled the U.S. opioid epidemic, the state of Oklahoma alleged at the start of the first trial to result from lawsuits over the drug crisis. | Video

29 May 2019

Johnson & Johnson's greed helped fuel U.S. opioid crisis, Oklahoma claims at trial

NORMAN, Okla. Johnson & Johnson's greed led the drugmaker to use deceptive marketing to create an oversupply of painkillers that fuelled the U.S. opioid epidemic, the state of Oklahoma alleged at the start of the first trial to result from lawsuits over the drug crisis. | Video

29 May 2019

REFILE-UPDATE 4-J&J's greed helped fuel U.S. opioid crisis, Oklahoma claims at trial

NORMAN, Okla., May 28 Johnson & Johnson's greed led the drugmaker to use deceptive marketing to create an oversupply of painkillers that fueled the U.S. opioid epidemic, the state of Oklahoma alleged at the start of the first trial to result from lawsuits over the drug crisis.

29 May 2019

UPDATE 2-Teva Pharm to pay Oklahoma $85 mln to settle opioid claims

BOSTON/JERUSALEM, May 26 Teva Pharmaceutical Industries Ltd said on Sunday it had agreed to pay an $85 million settlement with the state of Oklahoma days before the company was set to face trial over allegations that it and other drugmakers helped fuel the U.S. opioid epidemic.

26 May 2019

Earnings vs. Estimates